Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations

Official record

Identifier

NCT07751783

Recruiting locations

country

Taiwan

Interventions studied

structured exercise training

Lead sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital

Target enrolment

150 participants

Study type

INTERVENTIONAL

Phase

Not applicable

Status

Recruiting

First posted

Aug 7, 2026

Last updated on the registry

Aug 7, 2026

Age

18 Years – 80 Years

Sex

ALL

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

1. Aged 18 to 80 years.
2. Cancer Cohorts: Pathologically confirmed diagnosis of AJCC TNM stage I-III, and having completed curative-intent treatment (including surgery ± adjuvant chemotherapy/radiotherapy, etc) for at least 2 months.
3. Cancer cohort must have an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0-2.
4. Ability to comply with weekly structured exercise training (3-4 professionally supervised sessions per week) and willingness to accept telephone follow-ups or report exercise status via exercise logs/wearable devices.
5. Self-reported failure to meet the following physical activity guidelines within the past 3 months: at least 150 minutes of moderate-intensity aerobic exercise per week OR at least 75 minutes of vigorous-intensity aerobic exercise per week; AND no regular resistance training (≥ 2 sessions per week) within the past 3 months.

Exclusion Criteria:

1. Cardiovascular instability: History of acute coronary syndrome (ACS), myocardial infarction (MI), acute exacerbation of heart failure, or hospitalization for heart failure within the past 3 months; unstable angina; uncontrolled arrhythmia; or uncontrolled hypertension (resting blood pressure \> 180/110 mmHg).
2. Hypoxemia: Resting oxygen saturation (SpO2) \< 90%.
3. Metabolic instability: Severe hypoglycemic event or diabetic ketoacidosis (DKA) within the past 3 months.
4. Musculoskeletal or neurological risks: Unstable bone metastasis or bone metastasis with a high risk of fracture; recent major fracture or orthopedic surgery where weight-bearing is not yet permitted; or other severe neuromuscular diseases that compromise the safety of exercise.
5. Hematological risks: Thrombocytopenia (Platelet count \< 50,000/μL), severe anemia (Hemoglobin \[Hb\] \< 8 g/dL), or neutropenia (Absolute Neutrophil Count \[ANC\] \< 1,000/μL).
6. Deemed unsuitable for exercise intervention as determined by clinical assessment from the attending physician or study investigator.
7. Concurrent participation in other formal exercise or weight-loss intervention programs.
8. Inability to comprehend or complete the informed consent form, or inability to comply with the study procedures.

Indexed under

Liver Cancer